A Phase II Trial Finds Ixekizumab “Extremely Effective” and Safe for Psoriasis
More like this
- Many Clinical Studies May Not Be Dependable
- The 'Heartbreak of Psoriasis' Has Met Its Match!
- Psoriasis Patients' Options Include Effective Oral and Injectible Drugs
- Phase 3 Clinical Trials Support STELARA® (ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
- Cost-Effective Psoriasis Treatment May Demand Creative Coverage Rules